Prevalence of Fibromyalgia and [CFS] among Individuals with [IBS]: An Analysis of US National Inpatient Sample Database 2023 Tarar et al

Sly Saint

Senior Member (Voting Rights)
Prevalence of Fibromyalgia and Chronic Fatigue Syndrome among Individuals with Irritable Bowel Syndrome: An Analysis of United States National Inpatient Sample Database

Abstract:
Background and Aim:
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder associated with other somatic disorders. We studied the prevalence and predictors of fibromyalgia and chronic fatigue syndrome (CFS) in IBS patients.

Methods:
We used the National Inpatient Sample and included hospitalization of individuals with IBS, using ICD-10 codes, from 2016–2019. The prevalence and predictors of fibromyalgia and CFS in IBS patients were studied. Univariate and multivariate patient- and hospital-level regression models were used to calculate the adjusted odds of fibromyalgia and CFS in the IBS patient population.

Results:
Of 1,256,325 patients with an ICD-10 code of IBS included in the study, 10.73% (134,890) also had ICD-10 codes for fibromyalgia and 0.42% (5220) for CFS. The prevalence of fibromyalgia and CFS was significantly higher in IBS patients (adjusted odds ratio (AOR) 5.33, 95% confidence interval (CI) 5.24–5.41, p < 0.001, and AOR 5.40, 95% CI 5.04–5.78, p < 0.001, respectively) compared to the general adult population without IBS. IBS-diarrhea, IBS-constipation, and IBS-mixed types were independently associated with increased odds of fibromyalgia and CFS. Increasing age (AOR 1.02, 95% CI 1.01–1.04, p 0.003; AOR 1.02, 95% CI 1.01–1.03, p 0.001), female gender (AOR 11.2, 95% CI 11.1–11.4, p < 0.001; AOR 1.86, 95% CI 1.78–1.93, p < 0.001) and white race (AOR 2.04, 95% CI 1.95–2.12, p < 0.001; AOR 1.69, 95% CI 1.34–2.13, p < 0.001) were independent predictors of increased odds of fibromyalgia and CFS, respectively.

Conclusions:
It appears that IBS is associated with an increased prevalence of somatic disorders such as fibromyalgia and CFS.

https://www.mdpi.com/2227-9059/11/10/2594
 
Medical records being useless for this aside, it's a known co-mobordibity, in the case of ME/CFS it's listed in the criteria. Of course it's associated, damnit. This kind of research is completely useless, even more so that they look not at what is happening to the patients, but what gets recorded about them. Which is always wrong, to varying degrees.

This tells us nothing about the patients, what is happening to them, about prevalence or basically anything. A simple database query should be able to get data like this, it should take no more than 1 hour to get it, and yet this study probably cost hundreds of thousands and probably took years to complete. Medical research is like an experiment in using the most inefficient ways to do anything, and refusing to adapt. It has to be done this way, no matter how useless the results are.
 
A simple database query should be able to get data like this, it should take no more than 1 hour to get it, and yet this study probably cost hundreds of thousands and probably took years to complete.
As far as I can see it was a simple database query and stats package study, with no external funding and done by a group of people. My guess is a student group project.
 
Results of a recent study have drawn attention to the increased prevalence of medical comorbidities in patients with irritable bowel syndrome (IBS), highlighting the increased incidence of fibromyalgia and chronic fatigue syndrome in this group.

Results from a retrospective cohort study identified several factors, including increasing age, female gender, Caucasian race, obesity, smoking, and hyperlipidemia, as predictors of concurrent diagnosis of fibromyalgia and chronic fatigue syndrome in patients with IBS.1
Continues at:
https://oicanadian.com/study-identi...lgia-and-chronic-fatigue-in-ibs-patients/amp/
 
Back
Top Bottom